Publications in collaboration with researchers from Humanitas University (3)

2021

  1. Correction to: Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir (Infectious Diseases and Therapy, (2021), 10, 4, (2203-2222), 10.1007/s40121-021-00455-1)

    Infectious Diseases and Therapy

  2. Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir

    Infectious Diseases and Therapy, Vol. 10, Núm. 4, pp. 2203-2222

2018

  1. Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

    The Lancet Gastroenterology and Hepatology